Clinical Trials Logo

Stomach Neoplasms clinical trials

View clinical trials related to Stomach Neoplasms.

Filter by:

NCT ID: NCT03255811 Enrolling by invitation - Clinical trials for Advanced Gastric Cancer

Clinical Study on Treatment of Apatinib Mesylate in First-line Maintenance of Advanced Gastric Cancer

Start date: March 25, 2017
Phase: N/A
Study type: Interventional

At present, apatinib was approved for the treatment of advanced gastric cancer after second-line or gastroesophageal junction adenocarcinoma, is in the second one, experience of medication, clinical data, no chemotherapy so now intends to carry out 40 cases of small sample exploratory research, in the conventional chemotherapy after the onset, with APA for Nigeria maintenance treatment, with a preliminary understanding of apatinib in first-line advanced gastric cancer to maintain the efficacy and safety of the treatment, and explore the feasibility of anti generate small molecule targeted therapy in advanced gastric cancer vascular pattern.

NCT ID: NCT03228095 Enrolling by invitation - Colorectal Cancer Clinical Trials

Volatiles in Breath and Headspace Analysis - Diagnostic Markers

Volatolome
Start date: July 24, 2017
Phase:
Study type: Observational

Detection of Volatile Organic Compounds (VOC) directly from tissue by headspace analysis (skin, surgery material, other tissue) and exhaled breath is feasible using affordable user-friendly novel nano-chemo sensors that can accurately be used for screening and monitoring purpose

NCT ID: NCT03006263 Enrolling by invitation - Stomach Neoplasms Clinical Trials

Randomized Controlled Trials on Clinical Outcomes of Totally Laparoscopic Versus Laparoscopy Assisted Total Gastrectomy for Gastric Cancer

Start date: November 1, 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to explore clinical outcomes of totally laparoscopic versus laparoscopy assisted total gastrectomy for gastric cancer.

NCT ID: NCT03001726 Enrolling by invitation - Gastric Cancer Clinical Trials

To Observe the Efficacy and Safety by Comparing Chemotherapy(Docetaxel, Oxaliplatin Plus S1 ) Followed With Radical Resection Versus Chemotherapy Alone in Advanced Gastric Cancer With Single Non-curable Factor.

Start date: January 2017
Phase:
Study type: Observational

Investigators assessed the effectiveness of conversional gastrectomy compared with chemotherapy alone following docetaxel, oxalipaltin and S1 therapy for advanced gastric cancer with a single non-curable factor.

NCT ID: NCT02792881 Enrolling by invitation - Clinical trials for Remnant Gastric Cancer

The Safety, Feasibility and Oncological Outcomes of Laparoscopic Completion Total Gastrectomy for Remnant Gastric Cancer

Start date: June 2016
Phase: N/A
Study type: Interventional

This study aims to investigate the safety, feasibility, and long-term oncological outcomes of laparoscopic completion total gastrectomy for remnant gastric cancer.

NCT ID: NCT02789891 Enrolling by invitation - Stomach Neoplasms Clinical Trials

Randomized Controlled Trials on Laparoscopic No. 14v LNS Dissection

Start date: June 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to explore the short-term, long-term and oncological outcomes of laparoscopic No. 14v lymph node dissection in advanced lower third gastric cancer.

NCT ID: NCT02289183 Enrolling by invitation - Stomach Neoplasms Clinical Trials

Prospective Study on Modified Delta-shaped Gastroduodenostomy in Totally Laparoscopic Surgery for Distal Gastric Cancer

MDSG
Start date: January 1, 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to explore the clinical application value of modified delta-shaped gastroduodenostomy in totally laparoscopic surgery for distal gastric cancer.

NCT ID: NCT01637350 Enrolling by invitation - Gastric Cancer Clinical Trials

Digestive Tract Reconstruction After Gastrectomy of Gastric Cancer With Type 2 Diabetes

Start date: August 2012
Phase: N/A
Study type: Observational

Different digestive tract reconstruction will affect the blood glucose level of gastric cancer with type 2 diabetes. Subtotal gastrectomy with Billroth II reconstruction and total gastrectomy with Roux-en-Y reconstruction may help to improve glycaemic control which includes fasting blood glucose, postprandial blood glucose, glycosylated hemoglobin, C -peptide and body weight of gastric cancer patients with type 2 diabetes.

NCT ID: NCT01618474 Enrolling by invitation - Stomach Cancer Clinical Trials

Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients

Start date: May 2012
Phase: Phase 2
Study type: Interventional

This trial is going to evaluate the efficacy and safety of two regimens of DX (docetaxel plus capecitabine)and XELOX (oxaliplatin plus capecitabine)as adjuvant chemotherapy for stage IIIb-IIIc gastric cancer patients after curative D2/D2+ operation, and to investigate the optimal adjuvant regimen for such extremely high risk patients.

NCT ID: NCT00854854 Enrolling by invitation - Clinical trials for Advanced Gastric Cancer

Efficacy Study of TKcell in Advanced Gastric Cancer

Start date: January 2009
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine efficacy of NKCell combined FOLFOX-4 chemotherapy in gastric cancer